| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.029 | 0.7 |